Moderna, Inc. Common Stock vs. X4 Pharmaceuticals, Inc. Common Stock
MRNA
Moderna, Inc. Common Stock
$140.33 -3.59%
VS XFORX4 Pharmaceuticals, Inc. Common Stock
$3.50 -13.24%
Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| MRNA | XFOR | |
|---|---|---|
| Market Cap | $56.02 billion | $347.51 million |
| Revenue (TTM) | $2.23 billion | — |
| Net Income (TTM) | $-3,151,000,000 | — |
MRNA leads on 1 of 1 size & scale factors.
Valuation
| MRNA | XFOR | |
|---|---|---|
| Price / Book | 8.29 | 2.24 |
| Price / Sales | 25.15 | — |
XFOR leads on 1 of 1 valuation factors.
Profitability
| MRNA | XFOR | |
|---|---|---|
| Net Margin | -141.43% | — |
| Return on Equity | -46.61% | — |
MRNA and XFOR split the profitability factors evenly.
Risk & Sentiment
| MRNA | XFOR | |
|---|---|---|
| Short Interest | 0.01% | 0.08% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MRNA overview, MRNA financials, XFOR overview, XFOR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.